{"id":"W2142707978","doi":"10.1093/eurheartj/sur019","title":"Slowing heart rate with ivabradine: new treatment options","year":2011,"lang":"en","type":"article","venue":"European Heart Journal Supplements","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Ivabradine; Medicine; Cardiology; Internal medicine; Atenolol; Angina; Coronary artery disease; Myocardial infarction; Tolerability; Placebo; Heart rate; Anesthesia; Blood pressure; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009599138,0.0005917157,0.001116088,0.000718233,0.0001998025,0.0009846545,0.0008339658,0.001269036,0.005217427],"category_scores_gemma":[0.00061221,0.0001569111,0.0006692561,0.0005586905,0.0004947645,0.001395411,0.0004318626,0.004406392,0.001959356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003778473,"about_ca_system_score_gemma":0.0003864309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003806331,"about_ca_topic_score_gemma":0.001444403,"domain_scores_codex":[0.9997949,0.00004819716,0.00002446973,0.00003821303,0.00006234933,0.00003193105],"domain_scores_gemma":[0.9996715,0.0001080517,0.00006301807,0.00001439846,0.00006846863,0.00007448669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001446134,0.0008085519,0.0005072432,0.003225278,0.0001372722,0.0004935012,0.00008802846,0.0003939936,0.005016216,0.004795778,0.03406284,0.949025],"study_design_scores_gemma":[0.002940651,0.004844934,0.004832583,0.003578741,0.0003554772,0.002693244,0.0001823008,0.001032192,0.001617721,0.0106901,0.9671369,0.00009514709],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.003454065,0.9744834,0.001337138,0.01452742,0.00146359,0.0000388873,0.0001011011,0.00007306258,0.004521351],"genre_scores_gemma":[0.02128793,0.9557363,0.00341288,0.00903102,0.005164887,0.00009425174,0.0002824269,0.00002467865,0.004965565],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.005217427,"threshold_uncertainty_score":0.01745403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09736732628529346,"score_gpt":0.3237442819591124,"score_spread":0.2263769556738189,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}